Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor Agonist
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Related studies linked through entity extraction aliases.